Abiomed Net Income

The latest net income for ABMD is $270M as of September 2022. That compares with $150M in the prior-year period — up 78.9% year over year. That is below the Healthcare sector average of $16B. Investors often review this figure alongside Abiomed's historical trend and sector peers before judging valuation or financial health.

Over the past year, ABMD's net income moved from $150M to $270M — a 78.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Abiomed's operating scale or balance-sheet position.

Against Healthcare companies, ABMD currently prints $270M for net income, while the sector average sits near $16B. That is roughly 98.3% below the sector mean. Large gaps often invite a closer look at Abiomed's growth, margins, and balance sheet.

A net income figure of $270M for ABMD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $16B. Explore the charts below for those layers of context.

After noting ABMD's net income ($270M), review year-over-year change from $150M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.